Sarah Keppner

Polo-Like Kinase 1 as Predictive Marker and Therapeutic Target for Radiotherapy in Rectal Cancer

Franz Rödel, Sarah Keppner, Gianni Capalbo et al. · American Journal Of Pathology · 2010 · 67 citations · Full text

Medicine, Pathology, Rectal Cancer +10

Reaction-Driven <i>De Novo</i> Design, Synthesis and Testing of Potential Type II Kinase Inhibitors

Gisbert Schneider, Tim Geppert, Markus Hartenfeller et al. · Future Medicinal Chemistry · 2011 · 40 citations

Identification and Validation of a Potent Type II Inhibitor of Inactive Polo‐like Kinase 1

Sarah Keppner, Ewgenij Proschak, Gisbert Schneider et al. · ChemMedChem · 2009 · 35 citations

Pharmacotherapy, Cancer Biology, Tumor Biology +20

Biological impact of freezing Plk1 in its inactive conformation in cancer cells

Sarah Keppner, Ewgenij Proschak, Manfred Kaufmann et al. · Cell Cycle · 2010 · 30 citations · Full text

Drugs by Numbers: Reaction‐Driven De Novo Design of Potent and Selective Anticancer Leads

Birgit Spänkuch, Sarah Keppner, Lisa Lange et al. · Angewandte Chemie International Edition · 2012 · 26 citations

Drug Target, Engineering, Chemoprevention Strategy +18